None.
None.
Holdings compared (excluding cash instruments): 75 → 75.
| Holding | from | to |
|---|---|---|
| ELI LILLY & CO NPV | 16.62% | 15.79% |
| ROCHE HOLDINGS AG CHF NPV | 4.47% | 4.18% |
| GILEAD SCIENCES INC USD0.001 | 4.18% | 4.45% |
| Holding | 13 Aug | 1 Sept |
|---|---|---|
| ELI LILLY & CO NPV | 16.69% | 15.79% |
| ABBVIE INC USD0.01 | 11.18% | 11.36% |
| MERCK & CO. INC. USD0.5 | 6.70% | 7.29% |
| NOVARTIS AG-REG CHF0.5 | 4.59% | 4.79% |
| ASTRAZENECA PLC USD0.25 | 4.44% | 4.48% |
| GILEAD SCIENCES INC USD0.001 | 4.16% | 4.45% |
| ROCHE HOLDINGS AG CHF NPV | 4.43% | 4.18% |
| AMGEN INC USD0.0001 | 3.97% | 4.12% |
| ABBOTT LABORATORIES NPV | 3.98% | 3.82% |
| THERMO FISHER SCIENTIFIC INC USD1 | 3.31% | 3.28% |
Combined top-10 weight: 63.4% → 63.6%.
Bars scaled to the change: orange = up, grey = down. Basket percentages at the two snapshots.
| Country | 13 Aug | 1 Sept |
|---|---|---|
| United States | 83.3% | 83.1% |
| United Kingdom | 5.4% | 5.5% |
| Japan | 4.3% | 4.2% |
Nearly unchanged: beyond the largest countries, every move stays within ±0.2 points.
+1.3% in USD (NAV 6.96 → 7.06, 31 Aug → 3 Sept). Accumulating fund: no distributions.
| TER | 0.18% — unchanged |
| Transaction costs (KID) | 0.02% — unchanged |
| Index, name, policy | no change in the period |